IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+0.62%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$437M
AUM Growth
+$437M
(-22%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-28.81%
Top 10 Holdings %
Top 10 Hldgs %
31.44%
Holding
211
New
18
Increased
20
Reduced
105
Closed
27
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$21.9M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$11.5M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$9.39M |
| 4 |
Immatics
IMTX
|
$8.55M |
| 5 |
Zentalis Pharmaceuticals
ZNTL
|
$6.15M |
Top Sells
| 1 |
Biogen
BIIB
|
$26.5M |
| 2 |
Alector
ALEC
|
$14.1M |
| 3 |
CRISPR Therapeutics
CRSP
|
$10.3M |
| 4 |
Annovis Bio
ANVS
|
$8.86M |
| 5 |
Cullinan Oncology
CGEM
|
$7.61M |
Sector Composition
| 1 | Healthcare | 97.59% |
| 2 | Consumer Staples | 0.77% |
| 3 | Technology | 0.56% |
| 4 | Financials | 0.17% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCDA
51
DELISTED
Tricida, Inc. Common Stock
TCDA
| $3.11M | 0.22% |
670,771
-104,523
| -13% | -$485K |
|
|
DBVT
52
DBV Technologies
DBVT
$249M
| $3.11M | 0.22% |
310,110
-12,620
| -4% | -$127K |
|
53
Adicet Bio
ACET
$60.8M
| $3.08M | 0.22% |
392,418
+266,874
| +213% | +$2.09M |
|
54
ARK Genomic Revolution ETF
ARKG
$1.05B
| $3.06M | 0.22% |
40,961
| – | – |
|
|
STSA
55
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $2.93M | 0.21% |
629,384
-14,672
| -2% | -$68.4K |
|
|
RNTX
56
Rein Therapeutics, Inc. Common Stock
RNTX
$29M
| $2.82M | 0.2% |
2,763,583
-36,417
| -1% | -$37.1K |
|
|
HZNP
57
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.81M | 0.2% |
25,661
-29,154
| -53% | -$3.19M |
|
58
Ocular Therapeutix
OCUL
$2.25B
| $2.78M | 0.2% |
277,551
-142,022
| -34% | -$1.42M |
|
59
Sutro Biopharma
STRO
$85.6M
| $2.54M | 0.18% |
134,575
-785
| -0.6% | -$14.8K |
|
60
Liquidia Corp
LQDA
$2.52B
| $2.44M | 0.17% |
884,893
-5,542
| -0.6% | -$15.3K |
|
|
TAOX
61
Tao Synergies Inc. Common Stock
TAOX
$20.9M
| $2.44M | 0.17% |
245,629
-54,371
| -18% | -$540K |
|
62
Synlogic
SYBX
$17.4M
| $2.41M | 0.17% |
788,818
-59,536
| -7% | -$182K |
|
|
KA
63
DELISTED
Kineta, Inc. Common Stock
KA
| $2.36M | 0.17% |
228,761
+9,291
| +4% | +$95.8K |
|
64
Incyte
INCY
$17B
| $2.25M | 0.16% |
32,666
-3,867
| -11% | -$266K |
|
65
Eledon Pharmaceuticals
ELDN
$155M
| $2.13M | 0.15% |
344,578
-5,422
| -2% | -$33.5K |
|
66
Savara
SVRA
$591M
| $2.13M | 0.15% |
1,539,691
-47,046
| -3% | -$65K |
|
|
CDAK
67
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $1.96M | 0.14% |
+119,895
| New | +$1.96M |
|
68
Orchestra BioMed
OBIO
$147M
| $1.95M | 0.14% |
197,173
-2,827
| -1% | -$28K |
|
69
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.89M | 0.13% |
23,700
+46
| +0.2% | +$3.67K |
|
70
Gyre Therapeutics
GYRE
$734M
| $1.87M | 0.13% |
454,346
-126,854
| -22% | -$521K |
|
71
Quince Therapeutics
QNCX
$86.5M
| $1.85M | 0.13% |
20,160
-373
| -2% | -$34.2K |
|
72
MaxCyte
MXCT
$147M
| $1.83M | 0.13% |
+150,000
| New | +$1.83M |
|
73
Disc Medicine
IRON
$2.14B
| $1.7M | 0.12% |
421,050
-5,405
| -1% | -$21.8K |
|
74
KalVista Pharmaceuticals
KALV
$713M
| $1.69M | 0.12% |
96,576
-389
| -0.4% | -$6.79K |
|
75
VistaGen Therapeutics
VTGN
$113M
| $1.65M | 0.12% |
600,693
-315,859
| -34% | -$866K |
|